Keurig Dr Pepper
KDP
$32.73
-2.30%
Keurig Dr Pepper Inc. is a leading beverage company operating in the Consumer Defensive sector, specifically within the Non-Alcoholic Beverages industry. The company's core business encompasses manufacturing and distributing coffee systems, including Keurig brewers and single-serve K-Cup pods, as well as a portfolio of ready-to-drink beverages such as Dr Pepper, Snapple, and Canada Dry. It is a major player in North America, distinct for its dual-platform model combining a proprietary coffee ecosystem with a vast portfolio of branded soft drinks. The current investor narrative is dominated by its transformative $18 billion acquisition of JDE Peet's, announced in August 2025 and declared unconditional in March 2026, which aims to create a global coffee powerhouse and is expected to lead to a corporate split into separate North American beverage and global coffee entities, driving significant debate around integration risks, synergy realization, and strategic focus.…
KDP
Keurig Dr Pepper
$32.73
Related headlines
Investment Opinion: Should I buy KDP Today?
Rating & Thesis: KDP is a Hold. The core thesis is that the stock offers a compelling strategic narrative and reasonable valuation, but these are fully balanced by the high execution risk of its transformative acquisition, warranting a wait-and-see approach until post-deal clarity emerges.
Supporting Evidence: The forward P/E of 12.89x is reasonable for a defensive name and implies significant earnings growth from the estimated EPS of $3.13. Revenue growth accelerated to 10.54% YoY in Q4 2025, and profitability recovered sharply to a net margin of 7.85%. The stock trades at 69% of its 52-week range, suggesting room for recovery towards the $35.94 high if momentum continues, but lacks a clear analyst target for quantifying upside.
Risks & Conditions: The two biggest risks are integration failure of the JDE Peet's deal and further gross margin compression. This Hold rating would upgrade to a Buy if the company demonstrates successful early integration post-close, holds gross margins above 53%, and the stock's forward P/E remains below 13x. It would downgrade to a Sell if liquidity deteriorates (current ratio falls below 0.5), revenue growth decelerates below 5%, or the stock breaks below its recent support near $28. Relative to its own history and the transformative event, the stock appears fairly valued, pricing in both opportunity and risk.
Sign up to view all
KDP 12-Month Price Forecast
The investment case for KDP is at an inflection point, entirely hinging on the execution of its transformative acquisition and split. The recent price recovery and reasonable forward valuation suggest the market is giving management credit for the strategic move, but the low analyst coverage and mixed ratings reflect appropriate caution. The stance is neutral due to the balanced risk/reward; the potential upside from a successful split is compelling, but it is directly offset by the tangible risk of a large, complex integration. The stance would upgrade to bullish on confirmation of successful integration post-close and maintenance of current margins, or downgrade to bearish on any guidance miss or delay in the strategic plan.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Keurig Dr Pepper's 12-month outlook, with a consensus price target around $42.55 and implied upside of +30.0% versus the current price.
Average Target
$42.55
5 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
5
covering this stock
Price Range
$26 - $43
Analyst target range
Analyst coverage for KDP appears limited, with only 5 analysts providing estimates for revenue and EPS, indicating this may be a large-cap stock with selective or concentrated institutional coverage rather than broad follow-through. The consensus estimates point to expected revenue of $33.27 billion and EPS of $3.13 for the period ahead, but without a published average price target or explicit Buy/Hold/Sell distribution, it is difficult to quantify the implied upside or downside from the current price of $32.52. The available institutional ratings from major firms show a mixed but leaning positive sentiment, with recent actions including Wells Fargo and JP Morgan maintaining 'Overweight' ratings and B of A Securities maintaining a 'Buy', while Deutsche Bank and Barclays have 'Hold' or 'Equal Weight' stances; a notable downgrade occurred in December 2025 when Jefferies moved from 'Buy' to 'Hold', reflecting some caution amidst the major acquisition. The wide range between the low EPS estimate of $3.08 and high of $3.17 suggests a moderate degree of uncertainty, which is typical around a transformative corporate event like the JDE Peet's deal and planned split.
Bulls vs Bears: KDP Investment Factors
The evidence currently tilts slightly bullish, driven by a powerful technical recovery, attractive forward valuation, and a clear strategic catalyst in the JDE Peet's acquisition and split. However, the bear case is formidable, centered on the high-stakes risks of integrating a transformative $18 billion deal. The single most important tension in the investment debate is whether the promised synergies and strategic benefits of the acquisition and subsequent corporate split will materialize as planned, justifying the forward earnings growth priced into the stock, or if execution missteps will lead to further valuation compression and underwhelm the market's already cautious expectations.
Bullish
- Strong Recovery & Technical Momentum: The stock has gained 23.98% over the past three months and 10.05% in the last month, significantly outperforming the S&P 500 by 12.22 percentage points. This accelerating positive momentum from the 52-week low of $24.88 suggests a decisive trend reversal is underway.
- Attractive Forward Valuation: The forward P/E of 12.89x is significantly lower than the trailing P/E of 18.31x, reflecting market expectations for substantial earnings growth post-acquisition. The PEG ratio of 0.41 indicates the stock may be undervalued relative to its growth prospects.
- Robust Fundamental Recovery: Q4 2025 revenue grew 10.54% YoY to $4.499 billion, and the company swung from a net loss of -$144 million to a net income of $353 million. This demonstrates a strong operational turnaround with a healthy gross margin of 53.77%.
- Strong Cash Generation & Defensive Profile: The company generates substantial free cash flow ($1.505 billion TTM) to fund its acquisition, and its low beta of 0.424 provides defensive characteristics. The high short ratio of 6.36 also creates potential for a short-covering rally on positive news.
Bearish
- Major Acquisition & Integration Risks: The $18 billion JDE Peet's deal is transformative but carries significant execution and integration risks, as highlighted by a recent Jefferies downgrade from Buy to Hold. The wide range between analyst EPS estimates ($3.08 to $3.17) reflects substantial uncertainty around synergy realization.
- Valuation Compression from Historical Highs: The current trailing P/E of 18.31x is well below recent historical highs (e.g., 26.94x in Q4 2025), indicating the market has already de-rated the stock. Further multiple compression is a risk if the acquisition fails to deliver expected growth.
- Weak Liquidity & Margin Pressure: The current ratio of 0.64 indicates relatively low liquidity, which could be strained during the integration of a massive acquisition. Furthermore, the gross margin compressed from 55.95% to 53.77% YoY, signaling potential input cost pressures.
- Long-Term Underperformance vs. Market: Despite the recent rally, the stock is down 1.39% over the past year, underperforming the S&P 500 by over 22 percentage points. This suggests longer-term skepticism that the recent momentum must overcome.
KDP Technical Analysis
The stock is in a pronounced recovery trend from a significant low, having gained 23.98% over the past three months, which starkly contrasts with its 1-year decline of -1.39%. Currently trading at $32.52, the price sits approximately 69% of its 52-week range ($24.88 to $35.94), indicating it has recovered meaningfully from the lows but remains well below the yearly peak, suggesting room for further recovery if momentum persists. The 1-month price surge of 10.05% significantly outpaces the S&P 500's -2.17% return, demonstrating strong recent relative strength of 12.22 and accelerating positive momentum that diverges from the longer-term negative trend, potentially signaling a decisive trend reversal rather than a temporary bounce. Key technical levels are the 52-week low of $24.88, which now serves as major support, and the 52-week high of $35.94, representing the primary resistance; a breakout above $35.94 would confirm a new bullish phase, while a failure to hold recent gains could see a retest of support. The stock's beta of 0.424 indicates it is significantly less volatile than the broader market, which, combined with a substantial short ratio of 6.36, suggests a defensive profile but also potential for short-covering rallies on positive news.
Beta
0.42
0.42x market volatility
Max Drawdown
-28.1%
Largest decline past year
52-Week Range
$25-$36
Price range past year
Annual Return
-1.0%
Cumulative gain past year
| Period | KDP Return | S&P 500 |
|---|---|---|
| 1m | +9.0% | -1.3% |
| 3m | +27.4% | +14.0% |
| 6m | +16.9% | +9.5% |
| 1y | -1.0% | +20.9% |
| ytd | +18.0% | +9.5% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
KDP Fundamental Analysis
Revenue growth has been robust, with Q4 2025 revenue of $4.499 billion representing a 10.54% year-over-year increase, a significant acceleration from the prior year's Q4 revenue of $4.07 billion, indicating a strong recovery in the business trajectory. The company is solidly profitable, with Q4 2025 net income of $353 million and a net margin of 7.85%, a marked improvement from the net loss of -$144 million in Q4 2024; gross margin remains healthy at 53.77%, though it has compressed slightly from 55.95% a year ago, reflecting potential input cost pressures or mix shifts. The balance sheet shows moderate leverage with a debt-to-equity ratio of 0.63, and the company generates substantial cash, with trailing twelve-month free cash flow of $1.505 billion, providing strong internal funding capacity for its large acquisition; however, the current ratio of 0.64 indicates relatively low liquidity, which may be a focus as it integrates JDE Peet's.
Quarterly Revenue
$4.5B
2025-12
Revenue YoY Growth
+0.10%
YoY Comparison
Gross Margin
+0.53%
Latest Quarter
Free Cash Flow
$1.5B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is KDP Overvalued?
Given the company's positive net income, the primary valuation metric is the Price-to-Earnings (PE) ratio. The trailing PE stands at 18.31x, while the forward PE is notably lower at 12.89x, indicating the market expects significant earnings growth, likely fueled by the JDE Peet's acquisition and associated synergies. Compared to sector averages, the stock's valuation appears mixed; its forward PE of 12.89x is reasonable for a defensive consumer staples name, but its Price-to-Sales ratio of 2.29x and EV/EBITDA of 12.67x would need industry benchmarks for a precise premium/discount assessment, though the low PEG ratio of 0.41 suggests the market may be undervaluing its growth prospects. Historically, the current trailing PE of 18.31x is below the multi-year highs seen in recent quarters (e.g., 26.94x in Q4 2025 and 22.46x in Q1 2025), positioning it in the middle-to-lower end of its own historical range, which could represent a value opportunity if the acquisition and corporate split unlock expected value.
PE
18.3x
Latest Quarter
vs. Historical
Mid-Range
5-Year PE Range -76x~70x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
12.7x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks center on the company's ability to manage the $18 billion JDE Peet's acquisition without impairing its financial health. While free cash flow is strong at $1.505 billion TTM, the low current ratio of 0.64 indicates tight liquidity that could be pressured by integration costs. Furthermore, gross margin compression from 55.95% to 53.77% year-over-year highlights ongoing input cost or mix challenges that could erode profitability if not managed alongside the acquisition.
Market & Competitive Risks are dominated by valuation compression. The stock's trailing P/E of 18.31x is below its own recent historical highs, suggesting the market has already de-rated it due to acquisition uncertainty. As a defensive stock with a beta of 0.424, it also faces sector rotation risk out of consumer staples if economic sentiment improves. The transformative nature of the deal, noted as 'risky' in recent sector M&A commentary, introduces competitive and execution risks in consolidating the global coffee market.
Worst-Case Scenario involves a botched integration of JDE Peet's, where anticipated synergies fail to materialize, costs overrun, and the planned corporate split is delayed or cancelled. This could trigger analyst downgrades, a loss of investor confidence, and a re-rating to a deeper discount. The realistic downside could see the stock retesting its 52-week low of $24.88, representing a potential loss of approximately -23.5% from the current price of $32.52. The historical max drawdown of -28.13% provides a further gauge for severe adverse scenarios.
FAQ
The key risks are, in order of severity: 1) Execution & Integration Risk: The $18 billion JDE Peet's acquisition is complex, with failure to realize synergies being the primary threat. 2) Financial Risk: The low current ratio of 0.64 indicates tight liquidity during integration, and gross margin has compressed 218 basis points YoY. 3) Valuation & Sentiment Risk: The stock has underperformed the S&P 500 by over 22% in the past year, and its recovery is recent; renewed skepticism could lead to multiple compression. 4) Strategic Risk: The planned corporate split, while potentially value-creating, adds another layer of execution complexity and uncertainty.
The 12-month forecast centers on three scenarios with a base case target range of $32-$35. The Bull Case (30% probability) targets $35-$38, driven by successful acquisition integration and the value-unlocking split. The Base Case (50% probability) sees range-bound trading around $32-$35 as the market awaits proof of execution against the $3.13 EPS estimate. The Bear Case (20% probability) could see a retest of support near $25-$30 if integration challenges arise. The base case is most likely, predicated on the acquisition closing on schedule but the market requiring several quarters of evidence before a sustained re-rating higher.
KDP appears fairly valued relative to its near-term prospects. The forward P/E of 12.89x is reasonable for a defensive consumer staples company and implies significant earnings growth from the estimated $3.13 EPS. Historically, its trailing P/E of 18.31x is below recent highs above 26x, suggesting the market has already de-rated it for acquisition risk. The low PEG ratio of 0.41 hints at undervaluation on a growth-adjusted basis, but this is counterbalanced by the execution risk premium. The valuation implies the market is paying a fair price for the post-acquisition growth story but demands proof before awarding a higher multiple.
KDP presents a nuanced risk/reward profile. For investors comfortable with event-driven risk, the forward P/E of 12.89x and strategic split narrative could be attractive. The stock has 23.98% momentum over three months and significant analyst EPS growth expectations. However, the $18 billion acquisition carries high integration risk, reflected in mixed analyst ratings. It is a good buy for investors who believe in management's execution capability and are seeking a special situation, but it is not suitable for risk-averse investors seeking stable, predictable returns.
KDP is best suited for a medium to long-term investment horizon of 12-24 months. The stock's low beta of 0.424 provides some defensive stability, but the transformative corporate events (acquisition and split) will unfold over the next several quarters, making short-term trading highly speculative. The investment thesis is based on the value creation from the strategic split and synergy realization, which are long-term processes. Investors should be prepared to hold through potential volatility related to integration updates and have a minimum holding period of at least 12-18 months to allow the strategic plan to mature.